Fundraising Fox

Geneoscopy, Inc

St. Louis, US · Founded 2019 · Delaware corporation · 5 known investors

geneoscopy.com ↗

Geneoscopy develops innovative diagnostic technologies for gastrointestinal health, specifically focused on the detection of colorectal cancer. The company serves healthcare providers and patients seeking advanced diagnostic solutions in the medical diagnostics and cancer detection sector.

BiotechDigital HealthHealthtechMedical Devicesin /geneoscopy@GeneoscopyCo

Founders & leadership

AB
Andrew BarnellChief Executive Officer & Co-founder
EB
Erica BarnellCo-founder

Investors · 5

BioGenerator VenturesSt. Louis · $50K – $250K
Dorm RoomBrooklyn · $90K – $250K
iSelect FundSt. Louis · $250K – $2M
Missouri Technology CorporationSt. Louis
Cultivation CapitalreportedSt. Louis · $100K – $3.5M

Reported raises · per SEC filings

Form D private placements
▶$50.5MraisedNov 2021 · 85 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • JAMES MERSELISDirector
  • ERICA BARNELLExecutive Officer, Director
  • NAJEEB THOMASDirector
  • ANDREW BARNELLExecutive Officer, Director
  • MARK ZORENSKYDirector
  • DREW DENNISONDirector
  • BOBBY W. SANDAGE, JR.Director
Offering amount
$50.5M
Amount sold
$50.5M
Minimum investment
$1
First sale
May 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.9MraisedSep 2019 · 57 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • ANDREW BARNELLExecutive Officer, Director
Offering amount
$7.9M
Amount sold
$7.9M
First sale
Sep 2019
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news